CLINICAL_TRIALS
trial_result
· 2021-04-30
Clinical Trial Update: Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4) [Phase 3]
Summary
Phase 3 trial assessing vilaprisan for uterine fibroids was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Uterine Fibroids | Phase 3 | Status: TERMINATED | Results posted: 2021-04-30